Capital Asset Advisory Services LLC Charles River Laboratories International, Inc. Transaction History

Capital Asset Advisory Services LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	SELL	$183.71 - $210.25 $36,742 - $42,050	-200 Reduced 15.54%	1,087 $228,000
Q1 2023 May 12, 2023	SELL	$191.89 - $259.92 $12,089 - $16,374	-63 Reduced 4.67%	1,287 $259,000
Q4 2022 Mar 08, 2023	SELL	$197.11 - $250.07 $336,860 - $427,369	-1,709 Reduced 55.87%	1,350 $294,000
Q3 2022 Nov 14, 2022	SELL	$182.44 - $250.54 $241,185 - $331,213	-1,322 Reduced 30.18%	3,059 $602,000
Q2 2022 Aug 11, 2022	BUY	$204.13 - $302.4 $16,738 - $24,796	82 Added 1.91%	4,381 $937,000
Q1 2022 Apr 29, 2022	BUY	$255.51 - $362.11 $169,403 - $240,078	663 Added 18.23%	4,299 $1.22 Million
Q4 2021 Feb 04, 2022	BUY	$351.38 - $448.68 $71,330 - $91,082	203 Added 5.91%	3,636 $1.37 Million
Q3 2021 Oct 14, 2021	BUY	$372.64 - $458.3 $11,924 - $14,665	32 Added 0.94%	3,433 $1.42 Million
Q2 2021 Aug 06, 2021	BUY	$294.17 - $371.65 $104,430 - $131,935	355 Added 11.65%	3,401 $1.26 Million
Q1 2021 May 13, 2021	BUY	$249.67 - $299.48 $97,371 - $116,797	390 Added 14.68%	3,046 $883,000
Q4 2020 Mar 02, 2021	BUY	$222.0 - $252.62 $59,496 - $67,702	268 Added 11.22%	2,656 $664,000
Q3 2020 Nov 18, 2020	SELL	$175.56 - $226.45 $32,829 - $42,346	-187 Reduced 7.26%	2,388 $541,000
Q2 2020 Aug 14, 2020	BUY	$118.84 - $189.72 $4,991 - $7,968	42 Added 1.66%	2,575 $541,000
Q1 2020 May 18, 2020	BUY	$98.9 - $178.34 $35,999 - $64,915	364 Added 16.78%	2,533 $408,000
Q4 2019 Feb 13, 2020	BUY	$126.05 - $152.76 $270,377 - $327,670	2,145 Added 8937.5%	2,169 $376,000
Q4 2019 Feb 12, 2020	BUY	$126.05 - $152.76 $3,025 - $3,666	24 New	24 $316,000

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.56B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Capital Asset Advisory Services LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Asset Advisory Services LLC with notifications on news.